Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer

Fig. 1

Immunostaining of ADAM19 and its correlation with severity in human prostate cancer. ADAM19 immunostaining of (a) normal prostate, exhibiting hyperplasia; (b) prostate hyperplasia; (c) malignant prostate adenocarcinoma, grade II; and (d) malignant prostate adenocarcinoma, grade III. Photomicrographs are 200X magnification. Asterisk indicates stroma and arrow indicates glandular hyperplasia. ADAM19 staining is brown in colour. Haematoxylin counterstaining is purple in colour

Back to article page
\